Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease–Related Colorectal Neoplastic Lesions: The Role of Inflammation
Authors:
- Magali SvrcekMSMagali Svrcek
- Paula Maria Borralho NunesPNPaula Maria Borralho Nunes
- H-ECCO groupHGH-ECCO group
- 10 September 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 12 (12) , 1486-1498
Abstract
Compared to the general population, patients with inflammatory bowel disease (IBD) have an increased risk of developing colorectal cancer. Molecular mechanisms underlying colorectal carcinogenesis in the setting of IBD are not well understood. However, modern molecular investigative tools have facilitated the identification of features that help distinguish IBD-related carcinoma from sporadic. Moreover, with advances in endoscopic technology and improved understanding of the natural history, the management of colorectal neoplastic lesions in IBD patients has evolved. This review discusses the clinicopathological and molecular features of colorectal neoplastic lesions complicating IBD. Chronic inflammation is believed to promote the development of neoplasia, partly by producing reactive oxygen and nitrogen species (ROS and NOS) which may interact with genes involved in carcinogenetic pathways. Furthermore, alterations in microbiota and in the innate and adaptive immune responses might contribute, particularly by initiating, regulating and sustaining chronic inflammation. Earlier detection and better characterization of neoplastic colorectal lesions complicating IBD and a better knowledge of molecular mechanisms underlying carcinogenesis in this setting should facilitate improvements in the risk stratification of patients with longstanding IBD and in the management of dysplastic and malignant colorectal lesions that arise in this setting.Keywords
This publication has 81 references indexed in Scilit:
- Chronic ulcerative colitis and colorectal cancerCancer Letters, 2014
- Inflammatory Bowel Disease–associated Colorectal Cancers and Microsatellite InstabilityAmerican Journal of Surgical Pathology, 2013
- Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case–control studyCellular Oncology, 2011
- Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitisInflammatory Bowel Diseases, 2009
- Systematic review: molecular chemoprevention of colorectal malignancy by mesalazineAlimentary Pharmacology & Therapeutics, 2009
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated CancerCancer Cell, 2009
- High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitisScandinavian Journal of Gastroenterology, 2008
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005
- Increased prevalence of primary sclerosing cholangitis among first-degree relativesJournal of Hepatology, 2005
- Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitisThe Journal of Pathology, 2001